Scarica l'app Stockscreener
17.36
2.66%
0.45
Dopo l'orario di chiusura:
17.27
-0.09
-0.52%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Precedente Chiudi:
$16.91
Aprire:
$16.9
Volume 24 ore:
1.91M
Relative Volume:
0.98
Capitalizzazione di mercato:
$2.64B
Reddito:
$205.22M
Utile/perdita netta:
$-121.24M
Rapporto P/E:
-21.32
EPS:
-0.8141
Flusso di cassa netto:
$-82.81M
1 W Prestazione:
+0.81%
1M Prestazione:
+16.04%
6M Prestazione:
+135.87%
1 anno Prestazione:
+258.68%
Intervallo 1D:
$16.81
$17.76
Intervallo di 1 settimana:
$16.59
$17.76
Portata 52W:
$4.27
$17.89
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Nome
Adaptive Biotechnologies Corp
Settore
Industria
Telefono
206-659-0067
Indirizzo
1165 EASTLAKE AVE E, SEATTLE, WA
Confronta ADPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
17.36 | 2.57B | 205.22M | -121.24M | -82.81M | -0.8141 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Iniziato | Guggenheim | Buy |
| 2025-06-18 | Iniziato | Craig Hallum | Buy |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-12-21 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Underperform |
| 2022-06-03 | Iniziato | Piper Sandler | Neutral |
| 2022-02-16 | Reiterato | BTIG Research | Buy |
| 2022-02-16 | Reiterato | BofA Securities | Buy |
| 2022-02-16 | Reiterato | Goldman | Neutral |
| 2022-02-16 | Reiterato | JP Morgan | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-03-03 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Iniziato | Goldman | Buy |
| 2019-07-23 | Iniziato | BTIG Research | Buy |
| 2019-07-22 | Iniziato | BofA/Merrill | Buy |
| 2019-07-22 | Iniziato | Cowen | Outperform |
| 2019-07-22 | Iniziato | Goldman | Neutral |
| 2019-07-22 | Iniziato | Guggenheim | Buy |
| 2019-07-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Using Ichimoku Cloud for Adaptive Biotechnologies Corporation technicalsWeekly Trade Recap & Free Community Consensus Stock Picks - newser.com
What catalysts could drive Adaptive Biotechnologies Corporation stock higherTake Profit & Daily Profit Focused Stock Screening - newser.com
Can Adaptive Biotechnologies Corporation (1HM) stock expand revenue streamsVolume Spike & Verified Chart Pattern Signals - newser.com
How New Developments Are Shaping Analyst Views on Adaptive Biotechnologies’ Future - Yahoo! Finance Canada
How Adaptive Biotechnologies Corporation stock reacts to oil pricesJuly 2025 PostEarnings & Reliable Momentum Entry Alerts - newser.com
How Adaptive Biotechnologies Corporation stock compares to industry benchmarksQuarterly Investment Review & AI Forecasted Stock Moves - newser.com
How Adaptive Biotechnologies Corporation stock performs in high volatility marketsPortfolio Performance Report & Consistent Return Investment Signals - newser.com
Why Adaptive Biotechnologies Corporation stock could benefit from AI revolutionGDP Growth & Weekly Market Pulse Alerts - newser.com
Does Adaptive Biotechnologies Corporation fit your quant trading modelPortfolio Gains Summary & Reliable Intraday Trade Alerts - newser.com
Cwm LLC Sells 1,487 Shares of Adaptive Biotechnologies Corporation $ADPT - Defense World
Adaptive Biotechnologies (ADPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
How Adaptive Biotechnologies Corporation stock trades during market volatilityTrade Signal Summary & Daily Chart Pattern Signal Reports - newser.com
Adaptive Biotechnologies2025 Funding Rounds & List of Investors - Tracxn
Adaptive Biotechnologies (ADPT) Price Target Increased by 17.35% to 16.76 - Nasdaq
What dividend safety score for Adaptive Biotechnologies Corporation stockJuly 2025 Drop Watch & AI Optimized Trading Strategy Guides - newser.com
Technical signs of recovery in Adaptive Biotechnologies Corporation2025 Market Trends & Verified Entry Point Detection - newser.com
Is Adaptive Biotechnologies Corporation stock supported by innovation pipelineGap Down & Comprehensive Market Scan Insights - newser.com
Heatmap analysis for Adaptive Biotechnologies Corporation and competitorsBuy Signal & Expert Approved Trade Ideas - newser.com
Is Adaptive Biotechnologies Corporation stock a contrarian buyBear Alert & Community Consensus Picks - newser.com
How Adaptive Biotechnologies Corporation (1HM) stock performs during market turbulenceTrade Entry Summary & Community Verified Watchlist Alerts - newser.com
Will Adaptive Biotechnologies Corporation stock benefit from upcoming earnings reportsPortfolio Gains Summary & Growth Focused Entry Point Reports - newser.com
Exit strategy if you’re trapped in Adaptive Biotechnologies CorporationPortfolio Risk Summary & Real-Time Volume Trigger Notifications - newser.com
Adaptive Biotechnologies Corp Azioni (ADPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):